banning tirzepatide WADA just added (mounjaro) to the 2026 Monitoring Program FDA BANS Compounded Tirzepatide! Now

We provide guidance and support to help you make healthier choices, stay active, and maximize your results

Jorge presented findings from a study using data from the US multicenter electronic health record database TriNetX, showing that, among patients who had both T2D and SLE, those using GLP-1 RAs had lower risks for major adverse cardiac events (MACE), venous thrombosis, kidney disease progression, and all-cause mortality, compared with those using a different class of T2D medication

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1

Also, some research suggests that it crosses the blood-brain barrier more easily

And, if youre interested in learning more, you can read our other piece on getting a naturally sharp jawline with the help of microcurrent technology.